Trial intelligence / Profile preview

Dexmedetomidine sedation during neuraxial anesthesia for lower limb orthopedic surgery and circadian rhythm

ChiCTR2000028954Phase 4Recruiting

Sponsor
Union Hospital
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine in circadian rhythm sleep disorder (CRSD) (2 arms), sponsored by Union Hospital. Primary endpoints: Deep sleep quality score, Urinary dopamine concentration and 3 more. Started Jan 2020; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

circadian rhythm sleep disorder (CRSD)

Beyond the preview

Go deeper on ChiCTR2000028954.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000028954.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call